Home › Funds › Plato Investment Management Ltd › EW
Plato Investment Management Ltd position in EW
EDWARDS LIFESCIENCES CORP · Health Care
Plato Investment Management Ltd reported holding 22,627 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q2 2026 13F filing — a position valued at US$12.6M, representing 0.72% of its reported portfolio and ranking #24 among its reported holdings. Plato Investment Management Ltd has disclosed EW holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Plato Investment Management Ltd's EW position evolved
Plato Investment Management Ltd first disclosed a stake in EW in Q4 2023 at 695 shares (US$53K). The position peaked in Q2 2026 at 22,627 shares, worth US$12.6M. Across 11 filings, Plato Investment Management Ltd increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 22,627 shares valued at US$12.6M — an increase of 12,607 shares quarter over quarter.. Notable position changes include a 982% increase in Q1 2024 (shares fell 3% over the following quarter), a 92% increase in Q4 2025 (shares fell 6% over the following quarter), a 126% increase in Q2 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 695 | $52.99K | New |
| Q1 2024 | 7.52K | $718.71K | Add |
| Q2 2024 | 8.31K | $767.96K | Add |
| Q3 2024 | 4.56K | $300.68K | Reduce |
| Q4 2024 | 4.56K | $338.88K | Hold |
| Q1 2025 | 4.42K | $324.20K | Reduce |
| Q2 2025 | 4.42K | $344.81K | Hold |
| Q3 2025 | 4.42K | $341.51K | Hold |
| Q4 2025 | 8.51K | $728.93K | Add |
| Q1 2026 | 10.02K | $802.87K | Add |
| Q2 2026 | 22.63K | $12.57M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EW and 13F data
EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EW
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M sh · $1.18B · Q2 2026
- Ninety One UK Ltd 11.94M sh · $1.03B · Q3 2026
- Aristotle Capital Management, LLC 8.67M sh · $783.91M · Q2 2026
- BROWN ADVISORY INC 7.37M sh · $666.33M · Q2 2026
- Artisan Partners Limited Partnership 6.63M sh · $599.36M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 4.80M sh · $434.21M · Q2 2026
More on Plato Investment Management Ltd
FAQ
How long has Plato Investment Management Ltd held EW?
Plato Investment Management Ltd has disclosed EW holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is Plato Investment Management Ltd's current position in EW?
As of Q2 2026, Plato Investment Management Ltd holds 22.63K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $12.57M, representing 0.72% of its reported portfolio and ranking #24.
Has Plato Investment Management Ltd been buying or selling EW?
In the latest 13F filing (Q2 2026), Plato Investment Management Ltd increased its position in EW. The position peaked in Q2 2026 at 22.63K shares.
Which other funds hold EW?
Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.